These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 2958876)
21. A helper T cell clone produces an antigen-specific molecule (T-ABM) which functions in the induction of suppression. Green DR; Chue B; Zheng HG; Ferguson TA; Beaman KD; Flood PM J Mol Cell Immunol; 1987; 3(2):95-108. PubMed ID: 2978240 [TBL] [Abstract][Full Text] [Related]
22. Is the delayed-type hypersensitivity observed after a low dose of antigen mediated by helper T cells? Milon G; Marchal G; Seman M; Truffa-Bachi P; Zilberfarb V J Immunol; 1983 Mar; 130(3):1103-7. PubMed ID: 6218199 [TBL] [Abstract][Full Text] [Related]
23. T-T cell interaction in the induction of delayed-type hypersensitivity (DTH) responses: vaccinia virus-reactive helper T cell activity involved in enhanced in vivo induction of DTH responses and its application to augmentation of tumor-specific DTH responses. Takai Y; Kosugi A; Yoshioka T; Tomita S; Fujiwara H; Hamaoka T J Immunol; 1985 Jan; 134(1):108-13. PubMed ID: 3155458 [TBL] [Abstract][Full Text] [Related]
24. Effects of monoclonal antibodies directed against murine T lymphocyte cell surface antigens on lymphokine production by cloned T lymphocytes reactive with class I MHC or Mls alloantigens. Lancki DW; Prystowsky MB; Vogel SN; Beller DI; Dialynas DP; Fitch FW J Immunol; 1984 Oct; 133(4):2051-7. PubMed ID: 6236262 [TBL] [Abstract][Full Text] [Related]
25. Treatment of established tumor by adoptive immunotherapy with specifically immune T cells. Greenberg PD; Cheever MA Surv Immunol Res; 1985; 4(4):283-96. PubMed ID: 3879738 [No Abstract] [Full Text] [Related]
26. Exacerbation of murine cutaneous leishmaniasis by adoptive transfer of parasite-specific helper T cell populations capable of mediating Leishmania major-specific delayed-type hypersensitivity. Titus RG; Lima GC; Engers HD; Louis JA J Immunol; 1984 Sep; 133(3):1594-600. PubMed ID: 6205088 [TBL] [Abstract][Full Text] [Related]
27. A requirement for helper T cells in the induction of delayed-type hypersensitivity. Wright K; Ramshaw IA J Immunol; 1983 Apr; 130(4):1596-9. PubMed ID: 6187816 [TBL] [Abstract][Full Text] [Related]
28. IL-1 is an autocrine growth factor for T cell clones. Tartakovsky B; Finnegan A; Muegge K; Brody DT; Kovacs EJ; Smith MR; Berzofsky JA; Young HA; Durum SK J Immunol; 1988 Dec; 141(11):3863-7. PubMed ID: 2972778 [TBL] [Abstract][Full Text] [Related]
29. In vivo helper activity of autoreactive T cell clones. Tomonari K J Immunol; 1985 Sep; 135(3):1598-602. PubMed ID: 3160771 [No Abstract] [Full Text] [Related]
30. CD40-CD40Ligand interactions and their role in cytotoxic T lymphocyte priming and anti-tumor immunity. Toes RE; Schoenberger SP; van der Voort EI; Offringa R; Melief CJ Semin Immunol; 1998 Dec; 10(6):443-8. PubMed ID: 9826577 [TBL] [Abstract][Full Text] [Related]
31. Resolution of murine chlamydial genital infection by the adoptive transfer of a biovar-specific, Th1 lymphocyte clone. Igietseme JU; Ramsey KH; Magee DM; Williams DM; Kincy TJ; Rank RG Reg Immunol; 1993; 5(6):317-24. PubMed ID: 8068534 [TBL] [Abstract][Full Text] [Related]
32. Prophylaxis of graft-vs-host disease by adoptive transfer of a class II antigen-specific murine T-cell clone. Shih CC; Truitt RL Prog Clin Biol Res; 1987; 244():439-47. PubMed ID: 3116558 [No Abstract] [Full Text] [Related]
33. Activation of B cells by autoreactive T cells: cloned autoreactive T cells activate B cells by two distinct pathways. Finnegan A; Needleman B; Hodes RJ J Immunol; 1984 Jul; 133(1):78-85. PubMed ID: 6202794 [TBL] [Abstract][Full Text] [Related]
34. Therapy of disseminated tumors by adoptive transfer of specifically immune T cells. Greenberg PD; Klarnet JP; Kern DE; Cheever MA Prog Exp Tumor Res; 1988; 32():104-27. PubMed ID: 3287447 [No Abstract] [Full Text] [Related]
35. Role of IL-10 on antigen-presenting cell function for schistosomal egg-specific monoclonal T helper cell responses in vitro and in vivo. Flores Villanueva PO; Chikunguwo SM; Harris TS; Stadecker MJ J Immunol; 1993 Sep; 151(6):3192-8. PubMed ID: 8376775 [TBL] [Abstract][Full Text] [Related]
36. Induction of high-grade tumor-specific immunity in a host using a cytotoxic T-lymphocyte clone specific for a stable tumor antigen on murine leukemia L1210. Rahman SM; Kawashima K; Nakashima I; Nagase F Cancer Res; 1988 Nov; 48(22):6450-4. PubMed ID: 3263189 [TBL] [Abstract][Full Text] [Related]
37. Generation of lytic and proliferative lymphoid clones to syngeneic tumor: in vitro and in vivo studies. Rosenstein M; Rosenberg SA J Natl Cancer Inst; 1984 May; 72(5):1161-5. PubMed ID: 6609266 [TBL] [Abstract][Full Text] [Related]
38. The cytotoxic T-lymphocyte response against a poorly immunogenic mammary adenocarcinoma is focused on a single immunodominant class I epitope derived from the gp70 Env product of an endogenous retrovirus. Rosato A; Dalla Santa S; Zoso A; Giacomelli S; Milan G; Macino B; Tosello V; Dellabona P; Lollini PL; De Giovanni C; Zanovello P Cancer Res; 2003 May; 63(9):2158-63. PubMed ID: 12727834 [TBL] [Abstract][Full Text] [Related]
39. Recognition of Leishmania donovani antigens by murine T lymphocyte lines and clones. Species cross-reactivity, functional correlates of cell-mediated immunity, and antigen characterization. Sheppard HW; Scott PA; Dwyer DM J Immunol; 1983 Sep; 131(3):1496-503. PubMed ID: 6193191 [TBL] [Abstract][Full Text] [Related]
40. The CD4 antigen: physiological ligand and HIV receptor. Sattentau QJ; Weiss RA Cell; 1988 Mar; 52(5):631-3. PubMed ID: 2830988 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]